IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
IOL Chemicals and Pharmaceuticals Ltd
Operating Income
IOL Chemicals and Pharmaceuticals Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
|
Operating Income
₹1.2B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
30%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹67.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹58.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
22%
|
CAGR 10-Years
14%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹122.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
22%
|
CAGR 10-Years
4%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹28.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Operating Income
₹21.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
IOL Chemicals and Pharmaceuticals Ltd
Glance View
IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.
See Also
What is IOL Chemicals and Pharmaceuticals Ltd's Operating Income?
Operating Income
1.2B
INR
Based on the financial report for Dec 31, 2024, IOL Chemicals and Pharmaceuticals Ltd's Operating Income amounts to 1.2B INR.
What is IOL Chemicals and Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
30%
Over the last year, the Operating Income growth was -45%. The average annual Operating Income growth rates for IOL Chemicals and Pharmaceuticals Ltd have been -25% over the past three years , -27% over the past five years , and 30% over the past ten years .
You don't have any saved screeners yet